|
Volumn 24, Issue 9, 2002, Pages 821-829
|
Malignant tumors of the nasal cavity and paranasal sinuses
|
Author keywords
Nasal cavity; Nose neoplasms; Paranasal sinus neoplasms; Radiotherapy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADENOCARCINOMA;
ADENOID CYSTIC CARCINOMA;
ADENOSQUAMOUS CARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLINDNESS;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
ESTHESIONEUROBLASTOMA;
ETHMOID SINUS;
FEMALE;
FRONTAL SINUS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
NASOPHARYNX CANCER;
NOSE CAVITY CANCER;
OPTIC NERVE DISEASE;
ORBIT METASTASIS;
PARANASAL SINUS CANCER;
PRIORITY JOURNAL;
RETINOPATHY;
SALIVARY GLAND TUMOR;
SKULL BASE;
SPHENOID SINUS;
SQUAMOUS CELL CARCINOMA;
TRANSITIONAL CELL CARCINOMA;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
BLINDNESS;
CARCINOMA;
CAUSE OF DEATH;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NASAL CAVITY;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
NOSE NEOPLASMS;
OSTEORADIONECROSIS;
PARANASAL SINUS NEOPLASMS;
POSTOPERATIVE CARE;
PREOPERATIVE CARE;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
RISK FACTORS;
SURVIVAL RATE;
UNITED STATES;
|
EID: 0036720809
PISSN: 10433074
EISSN: None
Source Type: Journal
DOI: 10.1002/hed.10143 Document Type: Article |
Times cited : (225)
|
References (36)
|